| P2093 | author name string | G Zeppetella | |
| P2860 | cites work | Breakthrough pain: definition, prevalence and characteristics | Q33435886 |
| | A review of oral transmucosal fentanyl citrate: potent, rapid and noninvasive opioid analgesia | Q36109946 |
| | Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study | Q39441138 |
| | Characterization of breakthrough pain by hospice patients and their caregivers | Q39444429 |
| | Inhaled fentanyl as a method of analgesia | Q41237059 |
| | Treatment outcome in a multidisciplinary cancer pain clinic | Q48896694 |
| P433 | issue | 1 | |
| P921 | main subject | fentanyl | Q407541 |
| | pain management | Q621261 |
| P304 | page(s) | 57-58 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Palliative Medicine | Q7127852 |
| P1476 | title | Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain. | |
| P478 | volume | 14 | |